The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the signaling of interleukin (IL)-31.

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic dermatitis and delves into each option ...

Jason B. Pieper, DVM, MS, DACVD: …It is tough when we talk about atopic dermatitis, I mean, there's a variety [of causes].

Dermatitis refers to a number of skin conditions driven by inflammation, including atopic dermatitis (a type of eczema) and contact dermatitis. Dermatitis isn’t always curable, but it’s ...

Self-guided cognitive behavioral therapy was non-inferior in reducing atopic dermatitis symptom severity as clinician-guided ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial ...

Considering taking supplements to treat atopic dermatitis eczema? Below is a list of common natural remedies used to treat or reduce the symptoms of atopic dermatitis eczema. Follow the links to ...

Adult AD diagnoses were based on the modified Hanifin major criteria of a history of a chronic and relapsing course; pruritus; a pattern of facial and extensor eczema and xerosis at a younger age ...

The global atopic dermatitis treatment market is on the cusp of remarkable expansion, with projections indicating a surge in value from USD 15,048.6 million in 2024 to an impressive USD 45,501.6 ...